K. Elomaa

发表

Contraceptive vaginal rings releasing Nestorone and ethinylestradiol: a 1-year dose-finding trial.

D. Mishell, I. Sivin, H. Croxatto, 2005, Contraception.

Ovarian function during use of vaginal rings delivering three different doses of Nestorone.

D. Mishell, A. Faúndes, V. Brache, 2001, Contraception.

The Gaucher earlier diagnosis consensus point-scoring system (GED-C PSS): Evaluation of a prototype in Finnish Gaucher disease patients and feasibility of screening retrospective electronic health record data for the recognition of potential undiagnosed patients in Finland

K. Elomaa, M. Savolainen, K. Uusi-Rauva, 2021, Molecular genetics and metabolism reports.

Pharmacokinetics of 7 alpha-methyl-19-nortestosterone (MENT) delivery using subdermal implants in healthy men.

J. Suvisaari, S. I. Saleh, A. Moo-Young, 1999, Contraception.

Screening for potential undiagnosed Gaucher disease patients: Utilisation of the Gaucher earlier diagnosis consensus point-scoring system (GED-C PSS) in conjunction with electronic health record data, tissue specimens, and small nucleotide polymorphism (SNP) genotype data available in Finnish bioban

O. Carpén, K. Elomaa, K. Uusi-Rauva, 2022, Molecular genetics and metabolism reports.

The risk of escape ovulation under treatment with low-dose combined oral contraceptives

K. Elomaa, Kaisa Elomaa, 2001 .

Vaginal epithelial surface appearances in women using vaginal rings for contraception.

I. Fraser, D. Mishell, V. Brache, 2000, Contraception.

Variations in vaginal epithelial surface appearance determined by colposcopic inspection in healthy, sexually active women.

I. Fraser, M. Hickey, D. Mishell, 1999, Human reproduction.

Original research article The possible role of enterohepatic cycling on bioavailability of norethisterone and gestodene in women using combined oral contraceptives

J. Tuominen, S. Ranta, K. Elomaa, 2001 .

Charcoal treatment and risk of escape ovulation in oral contraceptive users.

J. Tuominen, S. Ranta, P. Lähteenmäki, 2001, Human reproduction.

The possible role of enterohepatic cycling on bioavailability of norethisterone and gestodene in women using combined oral contraceptives.

J. Tuominen, S. Ranta, P. Lähteenmäki, 2001, Contraception.

Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.

J. Deprest, I. Brosens, J. Tuominen, 1998, American journal of obstetrics and gynecology.

Ovulatory potential of preovulatory sized follicles during oral contraceptive treatment.

P. Lähteenmäki, K. Elomaa, 1999, Contraception.

Five-year clinical experiences with NOVA T 380 copper IUD.

I. Rauramo, K. Elomaa, M. Siljander, 2002, Contraception.

A 12-month comparative clinical investigation of a levonorgestrel-releasing intracervical device situated in the uterine cavity or cervical canal.

J. Tuominen, P. Lähteenmäki, K. Elomaa, 1996, Contraception.

Selection and performance of the levonorgestrel-releasing intrauterine system.

C. Bardin, M. Venhola, J. Tuominen, 1997, Acta obstetricia et gynecologica Scandinavica. Supplement.